STOCK TITAN

[Form 4] Bunge Global SA Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Bunge Global SA director Eliane Aleixo Lustosa de Andrade acquired 6,525 shares of the issuer's common stock on 09/02/2025. The transaction is reported on a Form 4 filed under Section 16 and shows the shares were received as restricted stock units pursuant to a dividend feature of the company's long-term incentive plans. The record lists a price of $82.44 and indicates the shares are held in a direct ownership form. The Form 4 was signed by an attorney-in-fact on 09/04/2025.

Eliane Aleixo Lustosa de Andrade, direttrice di Bunge Global SA ha acquisito 6,525 azioni ordinarie dell'emittente il 09/02/2025. La transazione, riportata in un Form 4 depositato ai sensi della Sezione 16, indica che le azioni sono state ricevute come restricted stock units in virtù di una clausola di dividendo dei piani di incentivazione a lungo termine della società. Il registro segnala un prezzo di $82.44 e specifica che le azioni sono detenute in forma di proprietà diretta. Il Form 4 è stato firmato da un procuratore il 09/04/2025.

Eliane Aleixo Lustosa de Andrade, directora de Bunge Global SA adquirió 6,525 acciones ordinarias del emisor el 09/02/2025. La operación se informa en un Formulario 4 presentado conforme a la Sección 16 y muestra que las acciones fueron recibidas como unidades de acciones restringidas en virtud de una cláusula de dividendos de los planes de incentivos a largo plazo de la compañía. El registro indica un precio de $82.44 y señala que las acciones se mantienen en forma de propiedad directa. El Formulario 4 fue firmado por un apoderado el 09/04/2025.

Bunge Global SA 이사 Eliane Aleixo Lustosa de Andrade2025-09-02에 발행회사의 보통주 6,525주를 취득했습니다. 이 거래는 섹션 16에 따라 제출된 Form 4에 보고되었으며, 해당 주식들이 회사의 장기 인센티브 플랜의 배당 조항에 따라 제한주식단위(RSU)로 수령되었다고 기재되어 있습니다. 명세서에는 $82.44의 가격이 기재되어 있으며 주식은 직접 소유 형태로 보유되고 있음을 나타냅니다. Form 4는 2025-09-04에 대리인(Attorney-in-fact)에 의해 서명되었습니다.

Eliane Aleixo Lustosa de Andrade, administratrice de Bunge Global SA, a acquis 6,525 actions ordinaires de l'émetteur le 09/02/2025. La transaction est signalée dans un Formulaire 4 déposé en vertu de la Section 16 et indique que les actions ont été reçues sous forme d'unités d'actions restreintes en vertu d'une disposition sur les dividendes des plans d'incitation à long terme de la société. L'enregistrement mentionne un prix de $82.44 et précise que les actions sont détenues en propriété directe. Le Formulaire 4 a été signé par un mandataire le 09/04/2025.

Eliane Aleixo Lustosa de Andrade, Direktorin von Bunge Global SA, erwarb am 09/02/2025 6.525 Stammaktien des Emittenten. Die Transaktion ist in einem gemäß Section 16 eingereichten Form 4 gemeldet und zeigt, dass die Aktien als Restricted Stock Units im Rahmen einer Dividendenregelung der langfristigen Incentive-Pläne des Unternehmens erhalten wurden. Im Eintrag ist ein Preis von $82.44 angegeben und es wird vermerkt, dass die Aktien in unmittelbarem (direktem) Eigentum gehalten werden. Das Form 4 wurde am 09/04/2025 von einem Bevollmächtigten unterzeichnet.

Positive
  • Director received equity alignment via 6,525 restricted stock units, aligning management and shareholder interests
  • Clear disclosure of transaction date (09/02/2025), amount (6,525 shares), and instrument (restricted stock units) in compliance with Section 16
Negative
  • None.

Insights

TL;DR: Routine insider award vesting increases director's stake; no trading disposition or material change to control.

The filing documents a non‑derivative acquisition of 6,525 common shares by a director via restricted stock units that vested under a dividend feature of the long‑term incentive plan. The transaction occurred at an indicated price of $82.44 on September 2, 2025, and is recorded as direct ownership. This appears to be a compensation‑related issuance rather than an open‑market purchase or sale, so it is typically not a liquidity or control event. For valuation or dilution impact, investors should compare the share amount to total outstanding shares (not provided here).

TL;DR: Standard executive compensation vesting; disclosure follows Section 16 reporting conventions.

The report clearly identifies the reporting person as a director and discloses acquisition of shares via plan‑based restricted stock units with a dividend feature. The filing was executed by an attorney‑in‑fact and includes the required Form 4 particulars (transaction date, amount, ownership form). This is a routine governance disclosure of compensation realization and does not indicate departure, related‑party transaction, or change in board composition based on the provided information.

Eliane Aleixo Lustosa de Andrade, direttrice di Bunge Global SA ha acquisito 6,525 azioni ordinarie dell'emittente il 09/02/2025. La transazione, riportata in un Form 4 depositato ai sensi della Sezione 16, indica che le azioni sono state ricevute come restricted stock units in virtù di una clausola di dividendo dei piani di incentivazione a lungo termine della società. Il registro segnala un prezzo di $82.44 e specifica che le azioni sono detenute in forma di proprietà diretta. Il Form 4 è stato firmato da un procuratore il 09/04/2025.

Eliane Aleixo Lustosa de Andrade, directora de Bunge Global SA adquirió 6,525 acciones ordinarias del emisor el 09/02/2025. La operación se informa en un Formulario 4 presentado conforme a la Sección 16 y muestra que las acciones fueron recibidas como unidades de acciones restringidas en virtud de una cláusula de dividendos de los planes de incentivos a largo plazo de la compañía. El registro indica un precio de $82.44 y señala que las acciones se mantienen en forma de propiedad directa. El Formulario 4 fue firmado por un apoderado el 09/04/2025.

Bunge Global SA 이사 Eliane Aleixo Lustosa de Andrade2025-09-02에 발행회사의 보통주 6,525주를 취득했습니다. 이 거래는 섹션 16에 따라 제출된 Form 4에 보고되었으며, 해당 주식들이 회사의 장기 인센티브 플랜의 배당 조항에 따라 제한주식단위(RSU)로 수령되었다고 기재되어 있습니다. 명세서에는 $82.44의 가격이 기재되어 있으며 주식은 직접 소유 형태로 보유되고 있음을 나타냅니다. Form 4는 2025-09-04에 대리인(Attorney-in-fact)에 의해 서명되었습니다.

Eliane Aleixo Lustosa de Andrade, administratrice de Bunge Global SA, a acquis 6,525 actions ordinaires de l'émetteur le 09/02/2025. La transaction est signalée dans un Formulaire 4 déposé en vertu de la Section 16 et indique que les actions ont été reçues sous forme d'unités d'actions restreintes en vertu d'une disposition sur les dividendes des plans d'incitation à long terme de la société. L'enregistrement mentionne un prix de $82.44 et précise que les actions sont détenues en propriété directe. Le Formulaire 4 a été signé par un mandataire le 09/04/2025.

Eliane Aleixo Lustosa de Andrade, Direktorin von Bunge Global SA, erwarb am 09/02/2025 6.525 Stammaktien des Emittenten. Die Transaktion ist in einem gemäß Section 16 eingereichten Form 4 gemeldet und zeigt, dass die Aktien als Restricted Stock Units im Rahmen einer Dividendenregelung der langfristigen Incentive-Pläne des Unternehmens erhalten wurden. Im Eintrag ist ein Preis von $82.44 angegeben und es wird vermerkt, dass die Aktien in unmittelbarem (direktem) Eigentum gehalten werden. Das Form 4 wurde am 09/04/2025 von einem Bevollmächtigten unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lustosa de Andrade Eliane Aleixo

(Last) (First) (Middle)
C/O BUNGE GLOBAL SA
1391 TIMBERLAKE MANOR PARKWAY

(Street)
CHESTERFIELD MO 63017

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Bunge Global SA [ BG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/02/2025 A 21(1) A $82.44 6,525 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents restricted stock units acquired on September 2, 2025 pursuant to a dividend feature under the registrant's long-term incentive plans.
Remarks:
/s/ Drew Yaeger, Attorney-in-Fact 09/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Bunge Global SA director Eliane Aleixo Lustosa de Andrade report on Form 4 (BG)?

She reported an acquisition of 6,525 shares of common stock on 09/02/2025 received as restricted stock units under the company's long‑term incentive plans.

Was the Form 4 transaction a purchase or compensation issuance for BG?

The filing states the shares represent restricted stock units acquired pursuant to a dividend feature of the registrant's long‑term incentive plans, indicating compensation issuance rather than an open‑market purchase.

What price is shown on the Form 4 for the BG transaction?

The Form 4 lists a price of $82.44 associated with the reported transaction.

How is the acquired BG stock held according to the Form 4?

The shares are reported as held in direct ownership form following the transaction.

Who signed the Form 4 for this BG filing and when?

The Form 4 bears the signature of Drew Yaeger, Attorney‑in‑Fact with date 09/04/2025.

Does the Form 4 indicate any sales or dispositions of BG stock by the reporting person?

No. The filing reports an acquisition of shares and does not show any dispositions.
Bunge Global SA

NYSE:BG

BG Rankings

BG Latest News

BG Latest SEC Filings

BG Stock Data

16.25B
165.60M
17.19%
74.66%
1.94%
Farm Products
Fats & Oils
Link
United States
GENEVA